215 related articles for article (PubMed ID: 23482667)
1. Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
Wong KK; Piert M
J Nucl Med; 2013 Apr; 54(4):590-9. PubMed ID: 23482667
[TBL] [Abstract][Full Text] [Related]
2. Regarding Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
Freesmeyer M
J Nucl Med; 2013 Dec; 54(12):2190. PubMed ID: 24198385
[No Abstract] [Full Text] [Related]
3. Reply: Regarding Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
Wong KK; Piert M
J Nucl Med; 2013 Dec; 54(12):2190-1. PubMed ID: 24198387
[No Abstract] [Full Text] [Related]
4. Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans.
Sheth S; Colletti PM
Clin Nucl Med; 2012 May; 37(5):e110-6. PubMed ID: 22475920
[TBL] [Abstract][Full Text] [Related]
5. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR
Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282
[TBL] [Abstract][Full Text] [Related]
6. Skeletal PET with 18F-fluoride: applying new technology to an old tracer.
Grant FD; Fahey FH; Packard AB; Davis RT; Alavi A; Treves ST
J Nucl Med; 2008 Jan; 49(1):68-78. PubMed ID: 18077529
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases.
Li Y; Schiepers C; Lake R; Dadparvar S; Berenji GR
Bone; 2012 Jan; 50(1):128-39. PubMed ID: 22001678
[TBL] [Abstract][Full Text] [Related]
8.
Ahuja K; Sotoudeh H; Galgano SJ; Singh R; Gupta N; Gaddamanugu S; Choudhary G
J Nucl Med Technol; 2020 Mar; 48(1):9-16. PubMed ID: 31811067
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
12. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
[TBL] [Abstract][Full Text] [Related]
13. (18)F-NaF PET/CT: EANM procedure guidelines for bone imaging.
Beheshti M; Mottaghy FM; Paycha F; Behrendt FFF; Van den Wyngaert T; Fogelman I; Strobel K; Celli M; Fanti S; Giammarile F; Krause B; Langsteger W
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1767-1777. PubMed ID: 26201825
[TBL] [Abstract][Full Text] [Related]
14. Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality?
Ohnona J; Michaud L; Balogova S; Paycha F; Nataf V; Chauchat P; Talbot JN; Kerrou K
Nucl Med Commun; 2013 May; 34(5):417-25. PubMed ID: 23470463
[TBL] [Abstract][Full Text] [Related]
15. Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?
Blake GM; Siddique M; Frost ML; Moore AE; Fogelman I
Bone; 2011 Sep; 49(3):537-42. PubMed ID: 21689803
[TBL] [Abstract][Full Text] [Related]
16. Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism.
Raynor W; Houshmand S; Gholami S; Emamzadehfard S; Rajapakse CS; Blomberg BA; Werner TJ; Høilund-Carlsen PF; Baker JF; Alavi A
Curr Osteoporos Rep; 2016 Aug; 14(4):115-25. PubMed ID: 27301549
[TBL] [Abstract][Full Text] [Related]
17. Normal bone and soft tissue distribution of fluorine-18-sodium fluoride and artifacts on 18F-NaF PET/CT bone scan: a pictorial review.
Sarikaya I; Elgazzar AH; Sarikaya A; Alfeeli M
Nucl Med Commun; 2017 Oct; 38(10):810-819. PubMed ID: 28777220
[TBL] [Abstract][Full Text] [Related]
18. Atlas of Extraosseous Findings Detected by 18F-NaF PET/CT Bone Scan.
Woodhead GJ; Avery RJ; Kuo PH
Clin Nucl Med; 2017 Dec; 42(12):930-938. PubMed ID: 29036001
[TBL] [Abstract][Full Text] [Related]
19. Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis.
Ng QKT; Sethi P; Saunders TA; Pampaloni MH; Flavell RR
Clin Nucl Med; 2018 Mar; 43(3):e89-e92. PubMed ID: 29261619
[TBL] [Abstract][Full Text] [Related]
20. A Case of Glioblastoma With Calcified Region Imaged With 18F-NaF PET/CT.
Ishimura M; Yamamoto Y; Mitamura K; Norikane T; Nishiyama Y
Clin Nucl Med; 2018 Oct; 43(10):764-765. PubMed ID: 30080686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
